Clinical Research Associate II Late Development

As a Clinical Research Associate you will be dedicated to one of our global pharmaceutical clients; with whom ICON shares a culture of innovation, flexibility and a common vision of bringing life-improving drugs to market. Leading by example, you can set the standard of excellence and enjoy a challenging career in our exclusive programs.

We are currently looking for a Clinical Research Associate II based in Paris and interested in Late Development. 

Key responsibilities include: 

• Full ownership of investigator sites for assigned studies with responsibility for the successful management of the site right through to close-out
• Planning and conducting various site visits (feasibility, site selection, interim and close-out) in accordance with the clinical monitoring plan
• Developing effective relationships with investigator site staff to ensure that key clinical metrics are met
• Preparing for and attending investigator meetings, coordinating the timely shipment and the subsequent proper storage and accountability of clinical supplies and following-up of drug safety issues
• Ensuring integrity of clinical data through an ability to sufficiently maintain site tracking records and work diligently to relevant guidelines

You will need:

• A first stable experience as a CRA (1-2 years), this within the pharmaceutical industry or a CRO
• Excellent organization skills
• Ability to work well in a dynamic environment and able to prioritize and respond to changing needs of the business
• Strong IT skills
• Strong communication with the ability to multitask and work effectively under pressure
• Fluency in French and professional proficiency in English

We believe our Clinical Operations team is second to none. You will receive the support you need to develop personally and professionally and work in an environment where you matter. Our team pushes forward together. United in solving problems, developing close site relationships and reaching the end goal. Operating as a key part of a global study team, the CRA plays a fundamental role in our clients’ drug development processes.